Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H24N4O2 |
Molecular Weight | 376.4516 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(N(C1CCN(CCC2=CC=CC=C2)CC1)C3=NC=CN=C3)C4=CC=CO4
InChI
InChIKey=BJZZDOLVVLWFHN-UHFFFAOYSA-N
InChI=1S/C22H24N4O2/c27-22(20-7-4-16-28-20)26(21-17-23-11-12-24-21)19-9-14-25(15-10-19)13-8-18-5-2-1-3-6-18/h1-7,11-12,16-17,19H,8-10,13-15H2
Molecular Formula | C22H24N4O2 |
Molecular Weight | 376.4516 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Mirfentanil was developed as CNS analgesic with a short duration of action. It induced antinociception predominately through mu opioid receptors. It was shown that at doses larger than those, which exert opioid effects, mirfentanil had nonopioid analgesic effects. The drug was successfully encapsulated in liposomes having a variety of compositions. The lipid composition of the formulation was varied to optimize the stabilization of liposomes and the encapsulation of solutes. Mirfentanil participated in phase II clinical trials for the treatment of pain. However, this study was discontinued.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects. | 1991 Aug |
|
Mirfentanil antagonizes morphine-induced suppression of splenic NK activity in mice. | 1996 Aug |
|
Mirfentanil and A-4334: Tritiation at high specific activity. | 2010 Jan |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:07:08 GMT 2023
by
admin
on
Fri Dec 15 19:07:08 GMT 2023
|
Record UNII |
Q2U943H24P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
List_of_fentanyl_analogues
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB08988MIG
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
117523-47-4
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
Q2U943H24P
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
CHEMBL161084
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
100000080644
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
C174864
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
DTXSID10151799
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
MIRFENTANIL
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
6690
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
MIRFENTANIL
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | Mirfentanil, at high doses, exhibits analgesic activity which is not fully reversed by opioid antagonists, suggesting that the drug has both opioid and non-opioid mechanisms of action. Side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear. | ||
|
C069209
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
60698
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY | |||
|
DB09175
Created by
admin on Fri Dec 15 19:07:08 GMT 2023 , Edited by admin on Fri Dec 15 19:07:08 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> AGONIST |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |